Study And Development Of FufangShengzhu Tiaozhikang Jiaonang

The compound prescription of Fufang ShengZhu TiaoZhiKang JiaoNang (FFSZTZK) is based on clinic research and embodys syndrome differentiation and treatment ,Biao-ben treatment at the same time. It is consist of glossy privet fruit, white atractylodes rhizome; eucommia bark; root of red-rooted salvia et al. It owns the effect of nourishing spleen and kidney, regulating liver qi, resolving phlegm ,cooling blood and removing toxin. It is also the pure Chinese medicine preparation and has no side effect. FFSZTZK has the good effect in decreasing blood lipids, bloodglucose, and regularing the blood rheology.Dyslipidemia is the common disease in clinic. Hyperlipemia is the reason that leads to atherosclerosis. If scleratheroma takes place in the large artery, especially in aortic arch or aorta ascendens, it may cause sandwich separation; if take place in brain ,it may cause cerebral infarction and cerebral hemorrhage; if take place in coronary artery, it may cause coronary heart disease and myocardial infarction; if take place in kidney , it may cause renal failure.It is reported in China that the prevalence rate of dyslipidemia is 18.6% and the dyslipidemia people in adult is about 160 million. Coronary heart disease(CHD) has high morbidity rate in developed concoury and also the one of the mainly reason of death in China.Dyslipidemia is the important hazards risk factor of atherosclerosis cerebrovascular disease.(ASCVD). It is reported in 1991 that there were about 120 million atherosclerosis patients in China and nearly 30 million people per year were...